Artificial intelligence is already driving major breakthroughs in medicine — from speeding up drug discovery to personalizing treatment. But according to Cato’s Dr. Jeffrey Singer, this progress comes from technological innovation and necessity, not Washington mandates. He argues Trump’s new executive order on AI is more about political posturing than scientific leadership:

“AI is already transforming medical research by analyzing vast datasets—genomics, imaging, clinical records—and turning them into actionable insights that improve diagnostics, speed drug discovery, and personalize treatment. This progress comes from technological advances and practical necessity, and it doesn’t need government involvement. At best, government can influence the pace or direction; at worst, political pressures can distort it. Trump’s executive order was less about leading and more about running to the front of the parade to look like he was.”

To speak with Dr. Singer directly, please reach out to Emily Salamon at esalamon@​cato.​org.